Cargando…

Brain volume is related to neurological impairment and to copper overload in Wilson’s disease

INTRODUCTION: To determine whether brain volume was associated with functional and neurological impairments and with copper overload markers in patients with Wilson’s disease. METHODS: In 48 treatment-naïve patients, we assessed functional and neurological impairments with the Unified Wilson’s Disea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smolinski, Lukasz, Litwin, Tomasz, Redzia-Ogrodnik, Barbara, Dziezyc, Karolina, Kurkowska-Jastrzebska, Iwona, Czlonkowska, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745045/ https://www.ncbi.nlm.nih.gov/pubmed/31147855 http://dx.doi.org/10.1007/s10072-019-03942-z

Ejemplares similares

Serum neurofilament light chain and initial severity of neurological disease predict the early neurological deterioration in Wilson’s disease
por: Ziemssen, Tjalf, et al.
Publicado: (2022)

Early neurological deterioration in Wilson’s disease: a systematic literature review and meta-analysis
por: Antos, Agnieszka, et al.
Publicado: (2023)

Copper Deficiency as Wilson’s Disease Overtreatment: A Systematic Review
por: Litwin, Tomasz, et al.
Publicado: (2023)

The Maternal and Fetal Outcomes of Pregnancy in Wilson’s Disease: A Systematic Literature Review and Meta-Analysis
por: Litwin, Tomasz, et al.
Publicado: (2022)

Liver transplantation as a treatment for Wilson’s disease with neurological presentation: a systematic literature review
por: Litwin, Tomasz, et al.
Publicado: (2022)

Characteristics of a newly diagnosed Polish cohort of patients with neurological manifestations of Wilson disease evaluated with the Unified Wilson’s Disease Rating Scale
por: Członkowska, Anna, et al.
Publicado: (2018)

Blood Based Biomarkers of Central Nervous System Involvement in Wilson’s Disease
por: Antos, Agnieszka, et al.
Publicado: (2023)

The sunflower cataract in Wilson’s disease: pathognomonic sign or rare finding?
por: Langwińska-Wośko, Ewa, et al.
Publicado: (2015)

D-Penicillamine-Induced Myasthenia Gravis—A Probable Complication of Wilson’s Disease Treatment—A Case Report and Systematic Review of the Literature
por: Antos, Agnieszka, et al.
Publicado: (2023)

Psychiatric manifestations in Wilson’s disease: possibilities and difficulties for treatment
por: Litwin, Tomasz, et al.
Publicado: (2018)

Optical coherence tomography as a marker of neurodegeneration in patients with Wilson’s disease
por: Langwińska-Wośko, Ewa, et al.
Publicado: (2017)

Treatment with d-penicillamine or zinc sulphate affects copper metabolism and improves but not normalizes antioxidant capacity parameters in Wilson disease
por: Grażyna, Gromadzka, et al.
Publicado: (2013)

Erratum to: Treatment with d-penicillamine or zinc sulphate affects copper metabolism and improves but not normalizes antioxidant capacity parameters in Wilson disease
por: Gromadzka, Grażyna, et al.
Publicado: (2014)

Blink reflex in newly diagnosed and treated patients with Wilson’s disease
por: Bembenek, Jan P., et al.
Publicado: (2021)

Transcranial sonography changes in heterozygotic carriers of the ATP7B gene
por: Skowronska, Marta, et al.
Publicado: (2020)

MR image mimicking the “eye of the tiger” sign in Wilson’s disease
por: Litwin, T., et al.
Publicado: (2014)

Transcranial Sonography in Mitochondrial Membrane Protein-Associated Neurodegeneration
por: Skowronska, Marta, et al.
Publicado: (2017)

Concordance rates of Wilson’s disease phenotype among siblings
por: Chabik, Grzegorz, et al.
Publicado: (2013)

Erratum to: Concordance rates of Wilson’s disease phenotype among siblings
por: Chabik, Grzegorz, et al.
Publicado: (2014)

Persistence with treatment for Wilson disease: a retrospective study
por: Masełbas, Wojciech, et al.
Publicado: (2019)

Diagnosis of Wilson Disease and Its Phenotypes by Using Artificial Intelligence
por: Medici, Valentina, et al.
Publicado: (2021)

Social and demographic characteristics of a Polish cohort with Wilson disease and the impact of treatment persistence
por: Maselbas, Wojciech, et al.
Publicado: (2019)

Cardiac assessment in Wilson’s disease patients based on electrocardiography and echocardiography examination
por: Buksińska-Lisik, Małgorzata, et al.
Publicado: (2017)

Optical coherence tomography and electrophysiology of retinal and visual pathways in Wilson’s disease
por: Langwińska-Wośko, Ewa, et al.
Publicado: (2015)

Sleep disturbances in newly diagnosed treatment-naïve patients with Wilson’s disease
por: Jernajczyk, Wojciech, et al.
Publicado: (2022)

Influence of BDNF polymorphisms on Wilson’s disease susceptibility and clinical course
por: Mirowska-Guzel, Dagmara, et al.
Publicado: (2013)

Changes in pre-hospital management of vascular risk factors among patients admitted due to recurrent stroke in Poland from 1995 to 2013
por: Bembenek, Jan P., et al.
Publicado: (2016)

Evaluation of liver fibrosis in patients with Wilson’s disease
por: Przybyłkowski, Adam, et al.
Publicado: (2020)

Dysregulated Choline, Methionine, and Aromatic Amino Acid Metabolism in Patients with Wilson Disease: Exploratory Metabolomic Profiling and Implications for Hepatic and Neurologic Phenotypes
por: Mazi, Tagreed A., et al.
Publicado: (2019)

Embolic strokes of undetermined source in a cohort of Polish stroke patients
por: Bembenek, Jan Pawel, et al.
Publicado: (2018)

The effect of gender on brain MRI pathology in Wilson’s disease
por: Litwin, T., et al.
Publicado: (2013)

Autoantibodies in Wilson disease: Impact on clinical course
por: Antczak‐Kowalska, Magdalena, et al.
Publicado: (2022)

Clinical significance of self-descriptive apathy assessment in patients with neurological form of Wilson’s disease
por: Leśniak, Marcin, et al.
Publicado: (2021)

Carotid intima media thickness and blood biomarkers of atherosclerosis in patients after stroke or myocardial infarction
por: Kurkowska-Jastrzębska, Iwona, et al.
Publicado: (2016)

Iron metabolism is disturbed and anti-copper treatment improves but does not normalize iron metabolism in Wilson’s disease
por: Gromadzka, Grażyna, et al.
Publicado: (2021)

Neurological Wilson’s Disease Signs—Hepatic Encephalopathy or Copper Toxicosis?
por: Jopowicz, Anna, et al.
Publicado: (2023)

Intestinal expression of metal transporters in Wilson’s disease
por: Przybyłkowski, Adam, et al.
Publicado: (2013)

Matrix Metalloproteinase 9 in Epilepsy: The Role of Neuroinflammation in Seizure Development
por: Bronisz, Elżbieta, et al.
Publicado: (2016)

Systemic deletion of Atp7b modifies the hepatocytes’ response to copper overload in the mouse models of Wilson disease
por: Muchenditsi, Abigael, et al.
Publicado: (2021)

Accurate Measurement of Copper Overload in an Experimental Model of Wilson Disease by Laser Ablation Inductively Coupled Plasma Mass Spectrometry
por: Kim, Philipp, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nd8o9asl8632i17v8glmtj8psq